Cerebrolysin 30 MG

Cerebrolysin is a peptide-based mixture derived from porcine brain proteins, developed for research purposes as a neurotrophic agent. It is primarily studied in laboratory settings for its potential effects on neuronal survival, neuroplasticity, and cognitive function. Preclinical studies have investigated Cerebrolysin in relation to experimental models of neurodegeneration, stroke, and traumatic brain injury.

Research involving Cerebrolysin commonly explores:

• Its role in promoting neuronal growth factor signaling and synaptic plasticity in cellular and animal models.
• Possible contributions to neuroprotection and recovery in models of ischemic injury and neurodegenerative disease.
• Experimental enhancement of cognitive performance and attenuation of neural inflammation in controlled research systems.
• Its activity in studies of neurorestoration, memory improvement, and brain repair mechanisms, where its peptide mixture composition and neurotrophic effects are topics of interest.
Cerebrolysin is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Cerebrolysin peptide mixture
• Purity: Not applicable (complex mixture)
• CAS Number: 924302-04-3
• Molecular Formula: Not defined (complex peptide mixture)
• Molecular Weight: Variable (peptide fragments)
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.